NCT04095572View on ClinicalTrials.gov

Alternative Prophylaxis in Female Recurrent Urinary Tract Infections

PHASE4RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 27, 2020

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2026

Conditions
Urinary Tract InfectionsUrinary Tract Infection (UTI)
Interventions
DRUG

intravesical instillation with HA-CS

intravesical instillation with HA-CS (Ialuril Prefill®, IBSA Farmaceutici Italia Srl, Lodi, Italy)

DRUG

intravesical instillation of sterile purified water

intravesical instillation of sterile purified water (packed and labelled according to Good Manufacturing Practice at IBSA Farmaceutici Italia Srl in Lodi, Italy to provide adequate blinding)

Trial Locations (2)

4031

RECRUITING

Department of Gynecology, University Hospital Basel, Basel

RECRUITING

Department of Urology, University Hospital Basel, Basel

Sponsors
All Listed Sponsors
collaborator

IBSA Institut Biochimique SA

INDUSTRY

lead

University Hospital, Basel, Switzerland

OTHER

NCT04095572 - Alternative Prophylaxis in Female Recurrent Urinary Tract Infections | Biotech Hunter | Biotech Hunter